Rosiglitazone and Glimepiride
Links shared publicly online about this topic
Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies - ONA
oncologynurseadvisor.com — “The FDA announced that after November 18, 2011, the diabetes drugs, Avandia (rosiglitazone), Avandamet (rosiglitazone/metformin), and Avandaryl (rosiglitazone/glimepiride) will be withdrawn from retail pharmacies by GlaxoSmithKline.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 19, 2011 at 7:39 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies http://goo.gl/fb/fVjBp
Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies - MPR
empr.com — “The FDA announced that after November 18, 2011, the diabetes drugs, Avandia (rosiglitazone), Avandamet (rosiglitazone/metformin), and Avandaryl (rosiglitazone/glimepiride) will be withdrawn from retail pharmacies by GlaxoSmithKline.” View full resource at empr.com
Most Recently Shared on May 19, 2011 at 7:43 pm By:
MPR News: Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies: The FDA announced that after N... http://bit.ly/iVU0KT
Symposier - Stronger Warnings about Heart Failure for Certain Diabetes Drugs
symposier.com — “Uploaded and Shared in Youtube by:hkllp The manufacturers of thiazolidinedione drugs have strengthened warnings about the risks of heart failure with these medications, which are use to treat type 2 diabetes. They are sold as Avandia (rosiglitazone maleate), Avandaryl (rosiglitazone maleate and glimepiride), and Avandamet (rosiglitazone maleate and metformin hydrochloride), which all contain rosiglitazone, and Actos (pioglitazone hydrochloride), Duetact (pioglitazone hydrochloride and glimepr” View full resource at symposier.com
Most Recently Shared on December 4, 2009 at 4:47 am By:
Symposier Cardiology Cardiology and Health Business
Heart Failure related to certain diabetes drugs -->http://bit.ly/6GfnO9 // Shared at Symposier site // Good night !!
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
Advertisement
